Cita APA

Vadivel, K., Zaiss, A. K., Kumar, Y., Fabian, F. M., Ismail, A. E. A., Arbing, M. A., . . . Bajaj, S. P. (2020). Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1. J Clin Med.

Citación estilo Chicago

Vadivel, Kanagasabai, Anne K. Zaiss, Yogesh Kumar, Frank M. Fabian, Ayman E. A. Ismail, Mark A. Arbing, Wallace G. Buchholz, William H. Velander, and S. Paul Bajaj. "Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R With C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1." J Clin Med 2020.

Cita MLA

Vadivel, Kanagasabai, et al. "Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R With C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1." J Clin Med 2020.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.